Literature DB >> 14986166

Severe Mycoplasma hominis infections in two renal transplant patients.

P Rohner1, I Schnyder, B Ninet, J Schrenzel, D Lew, T Ramla, J Garbino, V Jacomo.   

Abstract

Systemic infections due to Mycoplasma hominis are rare and occur mainly in immunocompromised patients. Reported here are the cases of two renal transplant patients with peritonitis who did not respond to empirical antimicrobial treatment. Effective treatment with doxycycline was administered only after definitive identification of Mycoplasma hominis was achieved. For this identification, the new genetic amplification-sequencing method was invaluable.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14986166     DOI： 10.1007/s10096-003-1097-x

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


  6 in total

1.  Mycoplasma hominis peritonitis after renal transplantation.

Authors:  A E van der Bijl; A M Kamper; J W de Fijter; L C Paul
Journal:  Nephron       Date:  2000-12       Impact factor: 2.847

Review 2.  Mycoplasma hominis infection in renal transplantation.

Authors:  Myriam Pastural; Vincent Audard; Marie-Pierre Bralet; Philippe Rémy; Laurent Salomon; Jacques Tankovic; Christian Brun Buisson; Philippe Lang
Journal:  Nephrol Dial Transplant       Date:  2002-03       Impact factor: 5.992

3.  Systemic Mycoplasma hominis infection in a patient immunocompromised due to combined transplantation of kidney and pancreas.

Authors:  W Geissdörfer; C Schörner; M Lohoff
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2001-07       Impact factor: 3.267

4.  Identification of bacteria recovered from clinical specimens by 16S rRNA gene sequencing.

Authors:  P Kiratisin; L Li; P R Murray; S H Fischer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-10-01       Impact factor: 3.267

5.  Isolation of Mycoplasma hominis on CDC anaerobic blood agar.

Authors:  I Filthuth; S Emler; E Jacobs; R Auckenthaler
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-11       Impact factor: 3.267

6.  Molecular diagnosis of bacterial endocarditis by broad-range PCR amplification and direct sequencing.

Authors:  D Goldenberger; A Künzli; P Vogt; R Zbinden; M Altwegg
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948
  6 in total
  6 in total

1.  Isolation of Mycoplasma hominis from extragenital cultures.

Authors:  C Miranda; E Camacho; G Reina; J Turiño; J Rodríguez-Granger; R Yeste; M F Bautista; M García; J C Alados; M De la Rosa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-05       Impact factor: 3.267

2.  Prevalence of urogenital mycoplasmas in women with systemic lupus erythematosus (SLE): preliminary study.

Authors:  Ekiel Alicja; Romanik Małgorzata; Aptekorz Małgorzata; Semik-Grabarczyk Elżbieta; Cieślik Paweł; Smolec Dominika; Jóźwiak Jarosław; Holecki Michał; Martirosian Gayane
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-12       Impact factor: 3.267

3.  Closed trauma, Mycoplasma hominis osteomyelitis, and the elusive diagnosis of Good's syndrome.

Authors:  Amanda Noska; Rawad Nasr; David Neville Williams
Journal:  BMJ Case Rep       Date:  2012-11-27

4.  Mycoplasma hominis necrotizing pleuropneumonia in a previously healthy adolescent.

Authors:  Andres Pascual; Marie-Helene Perez; Katia Jaton; Gaudenz Hafen; Stefano Di Bernardo; Jacques Cotting; Gilbert Greub; Bernard Vaudaux
Journal:  BMC Infect Dis       Date:  2010-11-24       Impact factor: 3.090

5.  Primary Peritonitis: An Index Case of Mycoplasma hominis Infection in a Healthy Female.

Authors:  Sabrina Drexel; Daniel Tseng
Journal:  Case Rep Surg       Date:  2018-02-06

6.  Multiple Intraabdominal Abscesses Caused by Mycoplasma hominis Infection Following Simultaneous Pancreas-Kidney Transplantation.

Authors:  Yumiko Okumura; Toshiki Kajihara; Yumiko Koba; Makoto Onodera; Toshinori Hara; Hiroyuki Tahara; Hideki Ohdan; Hiroki Ohge; Michiya Yokozaki; Motoyuki Sugai
Journal:  Ann Lab Med       Date:  2018-07       Impact factor: 3.464
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.